Updates in the Management of Migraine Headache: New Options to Enhance Outcomes

Migraine is a debilitating neurologic disorder that occurs in about 17% of women and 6% of men in the United States. It affects all aspects of life—from work and school attendance and performance to family life, leisure time, personal relationships, and finances. Unfortunately, migraine is often underdiagnosed and undertreated. This program will review the symptoms of and diagnostic criteria for migraine, appropriate use of traditional therapies, and the role of new and emerging therapies in the management of patients with episodic and chronic migraine.
Nada Hindiyeh, MD
Susan M. Tiso, DNP, APRN, FNP-BC

Interactive Virtual Presentation

Migraine is a debilitating neurologic disorder that occurs in about 17% of women and 6% of men in the United States. It affects all aspects of life—from work and school attendance and performance to family life, leisure time, personal relationships, and finances. Unfortunately, migraine is often underdiagnosed and undertreated. This program will review the symptoms of and diagnostic criteria for migraine, appropriate use of traditional therapies, and the role of new and emerging therapies in the management of patients with episodic and chronic migraine. 

Nada Hindiyeh, MD Susan M. Tiso, DNP, APRN, FNP-BC Released: January 24, 2020
Provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine

Boston University School of Medicine
Continuing Medical Education
72 East Concord Street, A402
Boston, Massachusetts 02118

(617) 638-4605
(617) 638-4905 (Fax)
http://www.bu.edu/cme

This activity is supported by an educational grant from
Teva Pharmaceuticals

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue